Results 241 to 250 of about 1,163,674 (252)

2016 US lymphoid malignancy statistics by World Health Organization subtypes

Ca-A Cancer Journal for Clinicians, 2016
Lindsay Morton, Ahmedin Jemal, James R Cerhan   +2 more
exaly  

Receptor and Microenvironment Dual-Recognizable Nanogel for Targeted Chemotherapy of Highly Metastatic Malignancy

Nano Letters, 2017
Haihua Xiao, Weiguo Xu, Jinjin Chen
exaly  

Dual malignancy in a thyroid; papillary thyroid carcinoma and small lymphocytic lymphoma; a report of a case with a cyto-histologic correlation

Diagnostic Cytopathology, 2017
Omar I Ahmed
exaly  

Synchronous dual hematological malignancies: new or underreported entity?

Hematology, 2018
Rouslan Kotchetkov, Erin Ellison
exaly  

Paraneoplastic opsoclonus-myoclonus-ataxia syndrome revealing dual malignancy

Neurological Sciences, 2016
Riadh Gouider, N Mejri, I Kacem
exaly  

Risk of a second malignancy related to the use of cytotoxic chemotherapy

Ca-A Cancer Journal for Clinicians, 1982
exaly  

Kelley malignancy index and ecology therapy

Ca-A Cancer Journal for Clinicians, 1970
exaly  

Hypercalcemia and cancer: Differential diagnosis and treatment

Ca-A Cancer Journal for Clinicians, 2018
Sarah B Fisher, Mimi Hu
exaly  

IL-17A levels in systemic lupus erythematosus associated with inflammatory markers and lower rates of malignancy and heart damage: Evidence for a dual role.

European Journal of Rheumatology, 2017
Johannes C Nossent, Warren Raymond
exaly  

Discovery of novel aminopyrimidine-hydroxamate derivatives as dual FLT3/HDAC inhibitors: Design, synthesis, and anti-hematologic malignancy evaluation

European Journal of Medicinal Chemistry
Hongming Huang, Yong Ling, Fansheng Ran
exaly